A large new analysis has found that women who used estrogen-only menopausal hormone therapy showed fewer of the brain changes ...

Alzheimer’s dementia is generally more prevalent in women than in men, and doctors believe that one reason why is the sudden ...

Estrogen-only menopause therapy in older women was linked to less Alzheimer’s brain pathology at autopsy but may not prevent ...

The new study is drawing fresh attention to a treatment whose use has steadily declined in the U.S. over the past two decades ...

Menopausal hormone therapy (MHT) use is associated with Alzheimer disease (AD)-related neuropathologic and clinical outcomes.

A study found that people who used estrogen-only menopausal hormonal therapy were less likely to show increased Alzheimer’s disease pathology, and lower chances of memory decline and a dementia ...

A new study suggests that women who used hormone therapy later in life may have had a lower risk of dementia and fewer signs ...

A Stanford study found estrogen-only menopausal hormone therapy linked to 35% lower Alzheimer's pathology and 39% lower ...

Women who used estrogen-only menopausal hormone therapy (MHT) had 35% lower odds of Alzheimer’s disease (AD) neuropathologic change at autopsy and 39% lower odds of clinician-defined dementia in a ...

The pharmaceutical industry is warning that estrogen patches continue to be in shortage in the U.S. as manufacturers struggle ...